← Back to Search

Behavioral Intervention

ePVA Monitoring System for Head and Neck Cancer

N/A

Waitlist Available

Led By Janet H. Van Cleave, PhD, RN

Research Sponsored by The University of Texas Health Science Center, Houston

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Individuals with histologically diagnosed head and neck cancer (HNC) undergoing curative radiation therapy with or without chemotherapy

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 weeks after completing radiation therapy

Awards & highlights

Study Summary

This trial tests a digital monitoring system to help detect uncontrolled symptoms in patients with head and neck cancer and provide timely interventions.

Who is the study for?

This trial is for English or Spanish speaking individuals with confirmed head and neck cancer, undergoing curative radiation therapy, with or without chemotherapy. It's also for clinicians treating these patients. People who don't meet these specific criteria are excluded.Check my eligibility

What is being tested?

The study tests the NYU Electronic Patient Visit Assessment (ePVA), a digital system for monitoring symptoms in real-time against usual care methods. The goal is to see if ePVA improves swallowing, taste, smell, and social functions after radiation therapy.See study design

What are the potential side effects?

Since this trial involves patient-reported outcomes rather than medication or invasive procedures, there are no direct side effects from interventions like drugs or surgery. However, participants may experience discomfort when discussing sensitive health issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have head and neck cancer and am receiving radiation to cure it, with or without chemotherapy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 weeks after completing radiation therapy

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 weeks after completing radiation therapy

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks after completing radiation therapy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Head and neck cancer (HNC) symptoms as assessed by the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaires (QLQ)

Secondary outcome measures

Acute Care Services Use as assessed by number of acute care visits

Acute Care Services Use as assessed by number of days of using acute care

Health-Related Quality of Life (HRQoL) as assessed by the EORTC QLQ-C30 Quality of Life Questionnaire (QLQ)

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: NYU Electronic Patient Visit Assessment (ePVA) plus Usual CareExperimental Treatment2 Interventions

Group II: Usual CareActive Control1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Usual Care

1990

Completed Phase 4

~7700

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

New York University Langone Perlmutter Cancer CenterUNKNOWN

Fox Chase Cancer CenterOTHER

227 Previous Clinical Trials

37,239 Total Patients Enrolled

University of KansasOTHER

147 Previous Clinical Trials

325,591 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many facilities are actively administering this trial?

"This investigation is taking place in 8 different medical centres, including the University of Kansas Cancer Center (Kansas City, KS), NYU Langone Perlmutter cancer Centre (Philadelphia, PA), and Fox Chase Cancer Center (Houston, TX)."

Answered by AI

Are there any opportunities for people to join this research endeavor?

"As per information published on clinicaltrials.gov, this clinical trial is no longer recruiting patients. It was first posted in January 2024 and last updated in September 2023. Despite the fact that they are not currently seeking candidates, there are 494 other studies actively engaged with patient recruitment at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations

Janet Van Cleave 2024. "Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06030011.